Table 1.
Demographic characteristics and baseline CD4 T-cell counts of HIV-seronegative patients, stratified by stage of liver fibrosis
| Characteristic | Total Patients |
Fibrosis stage 1 |
Fibrosis stage 2 |
Fibrosis stage 3 |
Fibrosis stage 4 |
Fibrosis stage 5 |
Fibrosis stage 6 |
|---|---|---|---|---|---|---|---|
| Sample size | 267 | 16 | 53 | 70 | 24 | 40 | 48 |
| Age (years) | 50 ± 7 | 48 ± 6 | 49 ± 6 | 51 ± 7 | 49 ± 8 | 52 ± 7 | 50 ± 7 |
| Gender | |||||||
| Male | 181 (68) | 10 (62.5) | 39 (74) | 47 (67) | 17 (71) | 27 (68) | 30 (62.5) |
| Female | 86 (32) | 6 (37.5) | 14 (26) | 23 (33) | 7 (29) | 13 (33) | 18 (37.5) |
| Race | |||||||
| White | 181 (68) | 14 (87.5) | 34 (64) | 45 (64) | 15 (63) | 26 (65) | 36 (75) |
| Black | 53 (20) | 2 (12.5) | 11 (21) | 17 (24) | 6 (25) | 7 (18) | 6 (13) |
| Asian | 3 (1) | 0 | 0 | 0 | 0 | 1 (3) | 2 (4) |
| Hispanic | 25 (9) | 0 | 8 (15) | 6 (9) | 2 (8) | 4 (10) | 4 (8) |
| Other | 4 (1) | 0 | 0 | 2 (3) | 1 (4) | 1 (3) | 0 |
| HCV viral load | |||||||
| High (IU/mL) | 148 (55) | 10 (62.5) | 28 (53) | 41 (59) | 14 (58) | 20 (50) | 27 (56) |
| Low (IU/mL) | 119 (45) | 6 (37.5) | 25 (47) | 29 (41) | 10 (42) | 20 (50) | 21 (44) |
| CD4 T-cell counts | |||||||
| Baseline (cells/mm3) | 1004 ± 400 | 955 ± 329 | 1021 ± 326 | 1017 ± 418 | 1125 ± 363 | 927 ± 347 | 944 ± 479 |
For categorical variables, data represented as number of patients (per cent of patients) in each category; for numerical variables, data represented as mean ± SD.